Pulmonary veno occlusive disease
Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension characterized by the blockage of small veins in the lungs. This disease is often misdiagnosed as pulmonary arterial hypertension due to the similarities in clinical presentation. However, the treatment and prognosis for these two conditions are significantly different.
Etiology[edit | edit source]
The exact cause of PVOD is unknown. However, it is believed to be associated with several factors including exposure to certain toxins such as chemotherapy drugs, organic solvents, and tobacco smoke. Genetic factors may also play a role, as mutations in the EIF2AK4 gene have been identified in some patients with familial PVOD.
Clinical Presentation[edit | edit source]
Patients with PVOD typically present with symptoms of progressive dyspnea (shortness of breath), fatigue, and signs of right heart failure such as edema (swelling) and ascites (fluid accumulation in the abdomen). On physical examination, patients may have a loud pulmonary component of the second heart sound, jugular venous distension, and hepatomegaly (enlarged liver).
Diagnosis[edit | edit source]
Diagnosis of PVOD can be challenging due to its rarity and the nonspecific nature of its symptoms. It is often misdiagnosed as other forms of pulmonary hypertension. Diagnostic tests may include echocardiography, pulmonary function tests, and right heart catheterization. However, the definitive diagnosis of PVOD is made by lung biopsy, which shows characteristic changes in the small veins of the lungs.
Treatment[edit | edit source]
Treatment of PVOD is primarily supportive, as there is currently no cure for the disease. Management strategies may include oxygen therapy, diuretics to manage fluid overload, and anticoagulation to prevent blood clots. Lung transplantation may be considered in severe cases.
Prognosis[edit | edit source]
The prognosis of PVOD is generally poor, with a median survival of 2 years from the time of diagnosis. However, survival can vary widely depending on the severity of the disease and the patient's response to treatment.
NIH genetic and rare disease info[edit source]
Pulmonary veno occlusive disease is a rare disease.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
